Cinolazepam

Last updated
Cinolazepam
Cinolazepam.svg
Cinolazepam3d.png
Clinical data
Trade names Gerodorm 40mg
AHFS/Drugs.com cinolazepam
Dependence
liability
High
Addiction
liability
Medium
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • US:Unscheduled
  • EU:Prescription drug
Pharmacokinetic data
Bioavailability 90–100%
Metabolism Hepatic
Onset of action 30 minutes to 1 hour
Elimination half-life 9 hours
Duration of action 9 hours
Excretion Renal
Identifiers
  • (RS)-3-[9-Chloro-6-(2-fluorophenyl)-4-hydroxy-3-oxo-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-2-yl]propanenitrile
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C18H13ClFN3O2
Molar mass 357.77 g·mol−1
3D model (JSmol)
Chirality Racemic mixture
  • FC1=CC=CC=C1C2=NC(C(N(CCC#N)C3=C2C=C(C=C3)Cl)=O)O
  • InChI=1S/C18H13ClFN3O2/c19-11-6-7-15-13(10-11)16(12-4-1-2-5-14(12)20)22-17(24)18(25)23(15)9-3-8-21/h1-2,4-7,10,17,24H,3,9H2 Yes check.svgY
  • Key:XAXMYHMKTCNRRZ-UHFFFAOYSA-N Yes check.svgY
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Cinolazepam [1] (marketed under the brand name Gerodorm) [2] is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Due to its strong sedative properties, it is primarily used as a hypnotic.

It was patented in 1978 and came into medical use in 1992. [3] Cinolazepam is mainly used in Romania and Slovakia; it not approved for sale in the United States or Canada.

References

  1. US Patent 4388313 Novel 3-hydroxy-1,4-benzodiazepine-2-ones and process for the preparation thereof
  2. Lannacher Romania (1999). "Gerodorm". Produse Gerot inregistrate in Romania (in Romanian). Archived from the original on 11 October 2006. Retrieved 17 August 2006.
  3. Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 530. ISBN   9783527607495.